Port E - Search Results

1

Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score.

Gordon NT, Alberty-Oller JJ, Fei K, Greco G, Gallagher EJ, LeRoith D, Feldman SM, Killilea B, Boolbol SK, Choi L, Friedman N, Pilewskie M, Port E, Tiersten A, Bickell NA. Gordon NT, et al. Among authors: port e. Ann Surg Oncol. 2021 Oct;28(11):5941-5947. doi: 10.1245/s10434-021-09748-8. Epub 2021 Apr 3. Ann Surg Oncol. 2021. PMID: 33813671

2

Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma.

Port ER, Tan LK, Borgen PI, Van Zee KJ. Port ER, et al. Ann Surg Oncol. 1998 Jan-Feb;5(1):23-7. doi: 10.1007/BF02303759. Ann Surg Oncol. 1998. PMID: 9524703

3

Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma.

Mann GB, Port ER, Rizza C, Tan LK, Borgen PI, Van Zee KJ. Mann GB, et al. Among authors: port er. Ann Surg Oncol. 1999 Sep;6(6):591-8. doi: 10.1007/s10434-999-0591-5. Ann Surg Oncol. 1999. PMID: 10493629

4

Patient reluctance toward tamoxifen use for breast cancer primary prevention.

Port ER, Montgomery LL, Heerdt AS, Borgen PI. Port ER, et al. Ann Surg Oncol. 2001 Aug;8(7):580-5. doi: 10.1007/s10434-001-0580-9. Ann Surg Oncol. 2001. PMID: 11508619

5

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.

Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS 3rd. Naik AM, et al. Among authors: port e. Ann Surg. 2004 Sep;240(3):462-8; discussion 468-71. doi: 10.1097/01.sla.0000137130.23530.19. Ann Surg. 2004. PMID: 15319717 Free PMC article.

6

18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.

Port ER, Yeung H, Gonen M, Liberman L, Caravelli J, Borgen P, Larson S. Port ER, et al. Ann Surg Oncol. 2006 May;13(5):677-84. doi: 10.1245/ASO.2006.03.035. Epub 2006 Mar 16. Ann Surg Oncol. 2006. PMID: 16538409

7

Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.

Port ER, Park A, Borgen PI, Morris E, Montgomery LL. Port ER, et al. Ann Surg Oncol. 2007 Mar;14(3):1051-7. doi: 10.1245/s10434-006-9195-5. Epub 2007 Jan 7. Ann Surg Oncol. 2007. PMID: 17206485

8

Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.

Port ER, Garcia-Etienne CA, Park J, Fey J, Borgen PI, Cody HS 3rd. Port ER, et al. Ann Surg Oncol. 2007 Aug;14(8):2209-14. doi: 10.1245/s10434-006-9237-z. Epub 2007 Feb 1. Ann Surg Oncol. 2007. PMID: 17268882

9

Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.

Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Port ER, Morrow M, Gemignani ML. Karam AK, et al. Ann Surg Oncol. 2009 Jul;16(7):1952-8. doi: 10.1245/s10434-009-0440-6. Epub 2009 Apr 18. Ann Surg Oncol. 2009. PMID: 19381724

10

Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.

Chung A, Schoder H, Sampson M, Morrow M, Port E. Chung A, et al. Among authors: port e. Ann Surg Oncol. 2010 Aug;17(8):2119-25. doi: 10.1245/s10434-010-0950-2. Epub 2010 Feb 17. Ann Surg Oncol. 2010. PMID: 20162459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page